Lantus Insulin: Link to Cancer Shaky
Links shared publicly online about this topic.
- 1,926total visits
Lantus Insulin: Link to Cancer Shaky
View full resource at diabetes.webmd.com
Tags: Diabetes, Diabetes Type 1 Medication, Diabetes Type 2 Medication, Diabetes Medication, Insulin, Type 2 Diabetes, Cancer, Lantus
Most Recently Shared on July 2, 2009 at 7:44 pm By:
webMD: Lantus Insulin: Link to Cancer Shaky http://tinyurl.com/lzkkyz Full http://tinyurl.com/nvqwm8
Also Shared By:
Sanofi rebuffs renewed Lantus cancer worries | Reuters
reuters.com — “LONDON (Reuters) - A Swedish study has rekindled concerns about a possible link between Sanofi's top-selling insulin drug Lantus and cancer, but the French drugmaker said on Wednesday the observational” View full resource at reuters.com
Most Recently Shared on December 7, 2011 at 11:37 am By:
Sanofi rebuffs renewed Lantus cancer worries: LONDON (Reuters) - A Swedish study has rekindled concerns about a ... http://t.co/QMPYBKTe
FDA Drug Safety Communication: Update to ongoing safety review of Lantus (insulin glargine) and possible risk of cancer
fda.gov — “[1-12-2011] The U.S. Food and Drug Administration (FDA) is updating the public about its ongoing safety review of Lantus (insulin glargine) and a possible increased risk of cancer.” View full resource at fda.gov
Most Recently Shared on January 13, 2011 at 2:37 pm By:
NCI Cancer Bulletin Health News
FDA provides update on review of possible link between diabetes drug, cancer risk: http://bit.ly/hVDraB
Sanofi Shares Fall on Concern Over Lantus Cancer Risk (Update3) - BusinessWeek
businessweek.com — “Sanofi-Aventis SA fell the most in a month in Paris trading on renewed concern that the Lantus diabetes treatment, the French drugmaker's top-selling product, may be linked to an increased risk of cancer.” View full resource at businessweek.com
Most Recently Shared on June 18, 2010 at 12:13 pm By:
Sanofi Shares Fall on Concern Over #Lantus Cancer Risk (Update3) http://tinyurl.com/2vohskq #diabetes #insulin
Study to determine link between insulin glargine and cancer
news-medical.net — “Type 2 diabetes and obesity are linked to an increased risk of certain cancers. Recently published studies suggested that insulin glargine (a synthetic insulin preparation marketed under the trade name Lantus), may be associated with a higher risk of certain cancers than other insulins or oral glucose lowering medications. However, these studies were unable to control for important factors such as obesity that may have driven the association.” View full resource at news-medical.net
Most Recently Shared on December 15, 2009 at 6:58 pm By:
Obesity News: Study to determine link between insulin glargine and cancer: Type 2 diabetes and obesity are linked... http://twurl.nl/bn1x0l
Medical News: EASD: Insulin Analogues, Cancer Linked, but No Causality Shown - in Meeting Coverage, EASD from MedPage Today
medpagetoday.com — “VIENNA -- Patients taking insulin-based drugs for diabetes appear prone to increased rates of cancer diagnosis, but there appears to be no special risk for insulin glargine (Lantus) compared with othe” View full resource at medpagetoday.com
Most Recently Shared on September 30, 2009 at 8:58 pm By:
Patients receiving insulin-based agents appear more likely to be diagnosed with cancer. More: http://bit.ly/2lxnxe
Medical News: EASD: Insulin Analogues, Cancer Linked, but No Causality Shown - in Meeting Coverage, EASD from MedPage Today
medpagetoday.com — “VIENNA -- Patients taking insulin-based drugs for diabetes appear prone to increased rates of cancer diagnosis, but there appears to be no special risk for insulin glargine (Lantus) compared with othe” View full resource at medpagetoday.com
Most Recently Shared on September 30, 2009 at 6:39 pm By:
EASD: Insulin Analogues, Cancer Linked, but No Causality Shown http://bit.ly/bTpZb
Sanofi to probe cancer link with insulin use | Reuters
reuters.com — “PARIS, Sept 29 (Reuters) - Sanofi Aventis onTuesday launched a research plan to probe the safety of insulin,including its Lantus diabetis drug. The research program is designed to generate” View full resource at reuters.com
Most Recently Shared on September 29, 2009 at 9:15 pm By:
Stéphane Potdevin Pharma, Health Social Media, and Health Marketing
RT @blogaceutics: Sanofi to probe cancer link with insulin use [Reuters] http://bit.ly/4gnM0B
Sanofi's Lantus avoids meltdown after cancer scare | Reuters
reuters.com — “* Prescriptions for diabetes treatment holding up * Analysts review worst-case forecasts for Lantus sales * Sanofi expected to reiterate confidence at H1 results * Shares up 2.6 percent By” View full resource at reuters.com
Most Recently Shared on July 28, 2009 at 2:26 pm By:
Ivan Oransky Doctor and Health Communicator
Sales of Lantus, long-acting insulin, hold up, despite studies possibly linking it to cancer RT @reutersBenHir http://is.gd/1R8Yc
Inconclusive research links glargine insulin (Lantus) with cancer - Diabetes UK
diabetes.org.uk — “Diabetes uk’s view on research linking glargine insulin (lantus) with certain cancers.” View full resource at diabetes.org.uk
Most Recently Shared on July 5, 2009 at 8:19 am By:
Inconclusive research links glargine insulin (Lantus) with cancer - http://tinyurl.com/n5gtyk
FDA Tells Patients to Stick With Diabetes Drug Linked to Cancer - Health News - Health.com
news.health.com — “Despite recent studies suggesting that the injected diabetes drug Lantus (insulin glargine) might boost cancer risk, the U.S. Food and Drug Administration on Wednesday urged patients who are on the medication to continue using it.” View full resource at news.health.com
Most Recently Shared on July 3, 2009 at 12:47 am By:
FDA Tells Patients to Stick With Diabetes Drug Linked to Cancer: Despite recent studies suggesting that the inje.. http://tinyurl.com/lhhsrw
Medical News: FDA Reviewing Safety Data for Insulin Glargine - in Cardiovascular, Diabetes from MedPage Today
medpagetoday.com — “WASHINGTON -- In light of four recently published studies showing a link between insulin glargine (Lantus) and cancer, the FDA announced it is reviewing safety for the drug, but urged diabetic patien” View full resource at medpagetoday.com
Most Recently Shared on July 1, 2009 at 9:56 pm By:
CARDIOLOGY• FDA Reviewing Safety Data for Insulin Glargine http://tinyurl.com/ms5lx2
Lantus and Cancer: Further Study Needed :: Diabetes Self-Management
diabetesselfmanagement.com — “Late last week, results from several european studies showing a possible link between lantus (insulin glargine) and cancer were published online in the journal diabetologia. health agencies such as the u.s. food and drug administration (fda) and the international diabetes federation (idf) have been swift in their response to the release of this information, indicating that the studies are not conclusive and that people with diabetes should not stop taking lantus without speaking to their doctors” View full resource at diabetesselfmanagement.com
Most Recently Shared on July 1, 2009 at 7:23 pm By:
Diabetes Self-Mgmt Health Site
#diabetes New Blog post by Diane Fennell: Lantus and Cancer: Further Study Needed http://bit.ly/3ZXIL
Diabetes treatment and cancer
webcast.easd.org — “Diabetes treatment and cancer” View full resource at webcast.easd.org
Most Recently Shared on June 30, 2009 at 7:23 am By:
EASD - Lantus insulin: a possible link with cancer which requires further investigation - http://tinyurl.com/ll5u9x
UPDATE 1-Sanofi dismissive of poor quality Lantus studies | Reuters
reuters.com — “* CEO warns against risk from junk science * Sanofi to work with others to probe Lantus risks further * Prospective randomised study not practical, takes too long (Adds details, background)” View full resource at reuters.com
Most Recently Shared on June 30, 2009 at 6:56 am By:
Ben Hirschler Health Communicator
Sanofi CEO comes out fighting on Lantus, with swipes at "poor quality studies" and "junk science" http://tinyurl.com/kpt4ma
Advertisement
WebMD_News
@WebMD_News
Lantus Insulin: Link to Cancer Shaky: Experts say patients should not worry about shaky data suggesting a possib.. http://tinyurl.com/nvqwm8
1 year ago...